Table 5 Univariate and multivariate logistic regression analysis to predict pathologic Gleason score upgrading among PIRADS ≤ 2 patients
From: Favorable intermediate risk prostate cancer with biopsy Gleason score of 6
| Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|
| OR | 95%CI | p-value | OR | 95%CI | p-value | |
| Age | 1.021 | 0.958–1.088 | 0.523 | |||
| Bdoy mass index | 1.100 | 0.925–1.307 | 0.280 | |||
| DM | 0.804 | 0.198–3.261 | 0.760 | |||
| HTN | 0.981 | 0.394–2.440 | 0.967 | |||
| Prostate volume | 0.984 | 0.962–1.007 | 0.173 | |||
| PSA | 0.991 | 0.844–1.164 | 0.915 | |||
| PSA density | 1.811 | 0.688–4.764 | 0.329 | |||
| Number of biopsy (12 vs. ≥ 13) | 0.615 | 0.196–1.933 | 0.406 | |||
| Mean percentage of positive core | 3.400 | 1.010–11.451 | 0.048 | 0.962 | 0.905–1.022 | 0.206 |
| Mean tumor length | 6.500 | 2.114–19.987 | 0.001 | 11.336 | 1.630–78.845 | 0.014 |
| Mean percentage of total tumor of core | 3.274 | 1.210–8.861 | 0.020 | 1.042 | 0.976–1.112 | 0.220 |